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Objective: The aim of this retrospective study was to evaluate aortic volume changes in patients with acute type B aortic
dissection (TBD), treated either by thoracic endovascular aortic repair (TEVAR) or conservatively.
Materials andMethods: From July 1996 throughMarch 2008, 76 patients presenting with acute TBDwere referred to our
department. To ensure a follow-up of at least 24 months, only 64 of them were included in the present study, with the
cut-off for inclusion being March 2006. Twenty-nine of these patients underwent TEVAR and 35 patients underwent
conservative treatment. Indications for TEVAR were life-threatening symptoms. Follow-up was performed postinter-
ventionally in patients after TEVAR and at 3, 6, and 12 months, and yearly thereafter in both groups. It included clinical
examinations, computed tomography (CT) scans, analysis of volume changes in true thoracic lumen (TTL), false thoracic
lumen (FTL), thoracic lumen (TL), abdominal lumen (AL), and aortic diameter measurements. In addition, the extent of
thrombosis and its influence on volume changes were assessed.
Results: Mean follow-up was 41 months after TEVAR and 46 months in the conservatively-treated patients. At 60
months, cumulative rates of freedom from dissection-related death and rupture-free survival were 82.6% and 93.1% in the
TEVAR group, respectively. They were 74.9% and 88.5% in the conservatively-treated group, respectively. In the
conservatively-treated patients, 3 patients died of late aortic rupture, 4 were converted to open surgery, and 2 to TEVAR.
Evaluation of volume changes showed better results in the TEVAR group within 24months. However, within 60months
the difference between the two groups was no longer relevant. Relating to thrombosis of the FTL, analyses showed
slightly better overall results and promotion of thrombus formation after TEVAR. However, at 60 months the results
showed a tendency towards approximation between the two groups.
Conclusion:Our data suggest that TEVAR seems to delay the natural course of the disease but not to stop it. ( J Vasc Surg
2009;49:20-8.)Acute type B aortic dissection (TBD) is defined as any
nontraumatic dissection involving the descending aorta
that appears within 14 days after the onset of symptoms.1
The treatment of choice for acute TBD remains a matter of
debate in the scientific community, but there is widespread
consensus that in-patients with uncomplicated acute TBD
conservative therapy is superior to open surgery.2-4 How-
ever, persistent pain, aortic dilatation, drug-resistant hyper-
tension, or dissection-related complications, such as rup-
ture, impending rupture, and end-organ ischemia are clear
indications for immediate intervention. As surgery contin-
ues to result in high mortality rates,5-8 depending on the
complexity of the aortic dissection, thoracic endovascular
aortic repair (TEVAR) has been emerging as a less invasive
and safe alternative to conventional surgery in patients with
aortic disease. For more than a decade now, many authors
have documented their experience with TEVAR.5,9-13
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20It is well known that an increase in aortic diameter raises
the risk of rupture, which is the most common cause of
disease-related mortality.14,15 Therefore, diameter and vol-
ume changes may be an important predictor for the out-
come of different therapy strategies and for the risk of
rupture. Most authors have used diameter measurements
only in the follow-up of TBD.16-18 We used both diametric
and volumetric measurements.
In a previous study, we reported on our results in
patients with acute TBD treated by TEVAR. This study
included volumetric measurements and their correlation
with the length of stent-graft-coverage and the number of
re-entry points, but the focus was placed on clinical as-
pects.19 The aim of the present retrospective study was to
evaluate volume changes in patients with acute TBD, who
underwent either TEVAR or conservative treatment, in-
cluding volumetric measurements of the true thoracic lu-
men (TTL), the false thoracic lumen (FTL), the thoracic
lumen (TL), and the abdominal lumen (AL) in both patient
groups. In addition, thrombosis of the false lumen was
assessed in both patient groups and the impact of throm-
bosis on aortic lumen changes was analyzed.
MATERIALS AND METHODS
Patients. From July 1996 through March 2008, a
total of 76 patients were referred to our department with
acute TBD. To ensure a follow-up of at least 24 months,
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the cut-off for inclusion being March 2006. Thirty-five of
them with uncomplicated TBD, including 11 women and
24 men (age range, 42-86 years; mean age, 66 years)
received conservative treatment and 29 patients including 8
women and 21 men (age range, 35-89 years; mean age, 64
years) underwent TEVAR. The decision for TEVAR was
made by a team of vascular and cardiovascular surgeons,
anesthesiologists, and interventional radiologists. Indica-
tions for TEVAR were intractable pain (n  12, 41.4%),
aortic branch compromise resulting in end-organ ischemia
(n 11, 37.9%), rapid aortic dilatation (n 4, 13.8%), and
rupture (n  2, 6.9%).
Intractable pain was defined as ongoing chest pain
despite conservative therapy18 and rapid aortic dilatation as
a diameter increase of more than 10% within 14 days after
the onset of symptoms. Endovascular treatment was per-
formed between 1 and 336 hours (mean, 50 hours) after
admission.
Extent of the dissections. In the patient group who
underwent TEVAR, the dissection extended into the iliac
arteries in 17 patients, into the abdominal aorta in 7 pa-
tients, and in 5 patients it was limited to the thoracic aorta.
In the conservatively-treated patients, the dissection ex-
tended into the iliac arteries in 17 patients, into the abdom-
inal aorta in 17 patients, and in 1 patient it was limited to
the thoracic aorta.
Diagnostic work-up. The diagnosis of dissection was
established on the basis of computed tomography (CT)
scans and/or angiography and clinical examination. In
each patient, contrast-enhanced helical CT with three-
dimensional (3D) vascular reconstruction from the apex of the
thorax down to the groin was obtained immediately after
admission and diagnostic angiography at the time of stent-
graft insertion. These studies provided the needed informa-
tion on length and diameter of the aortic lesion and anchor-
ing sites and about involvement of important thoracic and
abdominal branches, as well as the anatomy of the vessels
used for access.
Up to May 1999, CT examinations were performed
using a single detector computed tomography (SDCT)
scanner and from May 1999 to June 2006 using a four-row
multi-slice scanner. Since June 2006, data have been ac-
quired from a 64-row multidetector computed tomogra-
phy (MDCT) scanner (VCT, GE Medical Systems, Mil-
waukee, Wis) using a slice thickness of 0.625 mm with pitch
0.98 in the standard reconstruction kernel. Scans were
obtained using 120-150 mL of a nonionic contrast agent
(Ultravist, Schering, Berlin, Germany) administered at a
concentration of 300-370 mg I/mL and a flow rate of 4
mL/second. The raw data were transferred to an indepen-
dent workstation (Sun Ultra 60, Sun Microsystems, Moun-
tain View, Calif) running the Advantage Windows software
(AW 4.0, GE Medical systems, Milwaukee, Wis) for calcu-
lating 3D reconstructions.
Follow-up protocol. Conservatively-treated patients
were closely monitored by multiple CT scanning during
hospitalization. Patients treated by TEVAR were scannedpostinterventionally. After discharge, the follow-up proto-
col included clinical examination and enhanced spiral CT
scans at 3, 6, and 12 months, and yearly thereafter in both
groups. Additional scans and/or digital subtraction an-
giography (DSA) were performed as needed to address
specific problems. The 3D volume rendering reconstruc-
tions of the graft and the aorta were performed in order to
detect possible aneurismal degeneration of the aorta or
distortion and/or migration of the grafts. For the evalua-
tion of volume changes, the follow-up studies were com-
pared to the postinterventional studies in patients after
TEVAR and to the studies performed on admission in the
conservatively-treated group, respectively.
Diametric and volumetric measurements. The max-
imal aortic diameter was measured by hand on axial CT
slices. To avoid overestimation of the aortic diameter due
to tortuosity, diametric measurements were obtained per-
pendicular to the maximal diameter of the aorta.20
For volumetric measurements, which take about 20
minutes for each CT examination, the data obtained from
the CT scans were transferred to a dedicated workstation
(Sun Ultra 60, Sun Microsystems, Mountain View, Calif)
running the Advantage Windows software (AW 4.0, GE
Medical systems, Milwaukee, Wis) and using digital imag-
ing and communications in medicine (DICOM)-coded
data sets. The volumes of interest were outlined on each CT
slice manually with the cursor of the workstation. After this
procedure, volumes were assessed using the summation of
area technique. Further technical details of measurements
were described previously.21 Volumes were expressed in
milliliters. The TTL, the FTL, and the TL were measured
between the origin of the left subclavian artery and the
origin of the celiac trunk. The AL was measured between
the origin of the celiac trunk and the aortic bifurcation.
In addition to the mean volume changes, we also
documented the number of patients who showed volume
increase, volume decrease, or volume stagnation of the TL,
respectively. The cut-off was 10%.
Aneurismal dilatation of the aorta in the area immedi-
ately adjacent to the SG was defined as marked circum-
scribed dilatation of the aorta (volume 25% compared to
the segments proximal and distal to the dilated segment).
Patient selection for statistical analysis of diametric
and volumetric measurements. Of the 64 patients who
were included in the study, 6 were lost to follow-up, 12
died within 0-407 days, 2 were converted to TEVAR, and
3 had to be converted to open surgery 1, 20, and 22
months after admission. The remaining 41 patients, includ-
ing 20 patients treated by TEVAR (age range, 46-83 years;
mean age, 65 years) and 21 conservatively-treated patients
(age range, 42-80 years; mean age, 63 years) had a com-
plete and uninterrupted follow-up of 24 months. In 29 of
them, including 11 patients treated by TEVAR (group A,
age range, 46-81 years; mean age, 62 years) and 18 conser-
vatively-treated patients (group B, age range, 42-75 years;
mean age, 63 years) complete and uninterrupted follow-up
aortic
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statistical analysis of volumetric/diametric measurements
and thrombus assessment.
Thrombus assessment. In both groups, changes in
the degree of thrombosis were evaluated by comparing the
first available CT scan (the preinterventional scan in group
A and the scan obtained on admission in the conservatively-
treated patients, respectively) to that at 60 months. In
addition, the preinterventional CT scans were compared to
the postinterventional scans to show the impact of TEVAR
on the degree of thrombosis in group A. Missing throm-
bosis was identified by opacification of the FTL by contrast
agent, partial thrombosis by the presence of contrast and
thrombus in the FTL, and complete thrombosis by the
absence of contrast and complete occlusion of the FTL by a
thrombus.
Statistics. Continuous data were expressed using
means  standard deviation (SD) and medians; categor-
ical data were shown as frequencies. To assess normal
distribution in volumetric and diametric measurements,
Kolmogorov-Smirnov Test was applied. As the data showed
significant departure from Gaussian distribution, non-
parametric tests were used throughout the analyses. Friedman-
Test and Wilcoxon-Test were applied to investigate longi-
tudinal differences in volumetric and diametric measurements
within groups. Cumulative rates of rupture-free survival and
freedom from dissection-related death were evaluated by
Fig 1. Kaplan-Meier estimates of cumulative rates of f
acute type B dissection, either by thoracic endovascularmeans of Kaplan-Meier estimates. The 2 tests were usedto compare the influence of the degree of thrombosis on
volume changes in the TL (volume decrease of more
than 10%, volume stagnation, and volume increase of
more than 10%). Two-sided P values of  .05 were
considered statistically significant. All statistical analyses
were conducted using SPSS 15.00 (SPSS Inc, Chicago,
Ill) statistical software.
The first available volumetric result, that means the
postinterventional result after TEVAR and the result ob-
tained on admission in the conservatively-treated patients,
respectively, were defined to be 100%. All following mea-
surements were expressed in percentages and referred to
100%. The same method was applied to diametric measure-
ments.
RESULTS
Mean follow-up was 41 months (range, 0-97 months)
in patients after TEVAR and 46 months (range, 0-109
months) in the conservatively-treated patients.
Freedom from dissection-related death and rupture-
free survival. In the patients treated by TEVAR, freedom
from late dissection-related death was 82.6% (standard
error [SE] 7.1%) at 1, 2, and 5 years (Fig 1) and rupture-
free survival (Fig 2) was 93.1% (SE 4.7%) at 1, 2, and 5
years. There was no late rupture in this group.
In the conservatively-treated patients, freedom from
late dissection-related death was 88.1 % (SE 5.6%) at 1 year
m from dissection-related death in patients treated for
repair or conservatively.reedoand at 2 years and 74.9% (SE 8.5%) at 5 years (Fig 1) and
r con
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years and 88.5% (SE 6.4%) at 5 years (Fig 2). There were
three late ruptures in this group.
Rupture. In the conservatively-treated group, 3 pa-
tients died of aortic rupture, 5, 6, and 51 months after
admission, respectively. In none of these patients did the
CT scans performed during hospitalization show any aortic
volume changes. In the first of them, the 3-month
follow-up CT scan showed that aortic volumes had not
changed compared to those seen on admission, that the
maximal aortic diameter did not exceed 40 mm and that the
FTL was not thrombosed. Aortic rupture occurred at the
level of the kidneys a few days prior to the 6-month
follow-up.
In the second patient, the scan on admission showed
that, apart from the dissection, the aorta was enlarged
along its entire course with the maximal aortic diameter
measuring 80 mm and that the FTL was not throm-
bosed. Surgical treatment was not possible, as the patient
was in severe medical condition and TEVAR could not
be performed, because none of the SGs available has a
diameter of more than 46 mm. The patient missed the
3-month follow-up and aortic rupture occurred within
the descending aorta also a few days prior to the 6-month
follow-up.
The patient who died of aortic rupture 51 months after
admission was followed as mentioned above. The CT scans
at the 48-month follow-up revealed volume increase of up
to 122% in the TTL, of up to 262% in the FTL, and of up to
Fig 2. Kaplan-Meier estimates of cumulative rates of
dissection, either by thoracic endovascular aortic repair o181% in the TL. The maximal aortic diameter had increasedfrom 35 mm on admission to 47 mm at the 48-month
follow-up and the FTL was partially thrombosed. Al-
though, the patient was regularly informed about the ne-
cessity of surgical or endovascular treatment, he declined
any further intervention.
Conversions to open surgery or to TEVAR due to
aortic dilatation. In the group treated by TEVAR, there
were no conversions to open surgery. As all patients in
whom aortic dilatation indicated failure of TEVAR were in
reduced medical condition, we preferred conservative man-
agement to surgical repair, because conversion from endo-
vascular aortic repair to open surgery is associated with a
high mortality.22
In the conservatively-treated patient group, 4 had to be
converted to open surgery, 1, 20, 22, and 51 months,
respectively, after the imaging performed on admission.
In the first 3 of them, CT scans were performed because
of sudden onset of intractable pain. The maximal aortic
diameter was 49, 48, and 42 mm, respectively. However, as
these patients presented in good clinical condition and as
we agree with Lopera et al,15 who stated that endovascular
treatment of chronic TBD is very difficult, they were re-
ferred to vascular surgery.
The patient who was converted to open surgery 51
months after his first CT has been described above. His
aortic diameter was 47 mm at 48 months. Three months
later, he presented with aortic rupture and, unfortunately,
surgical therapy was not successful and he died.
Two of the conservatively-treated patients had to be
ure-free survival in patients treated for acute type B
servatively.ruptconverted to TEVAR due to rapid aortic dilatation, one of
, false
c repa
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first imaging.
One of them received 3 SGs, which were implanted in a
telescope fashion, the other one received 1 SG. Total graft
length was 205 mm (range, 160-250 mm). As the patients
were in severe clinical condition, we preferred TEVAR to
open surgery.
Volumetric analysis. Results of volumetric measure-
ments are given in Figs 3-5 for both patient groups.
In group A, we observed a continuous and significant
increase in TTL volume during the entire observation
period (P  .003 from 0-6 months, P  .003 from 0-24
months and P  .003 from 0-60 months) and a non-
significant decrease in FTL volume during the first 2 years
(P  .131 from 0-6 months and P  .477 from 0-24
months), followed by a non-significant volume increase for
the remaining observation period (P  .286 from 0-60
Fig 3. Volume courses of true thoracic lumen, false tho
by thoracic endovascular aortic repair. Mean values  SD
percentages are shown. TTL, True thoracic lumen; FTL
standard deviation; TEVAR, thoracic endovascular aortimonths). The TL volume increased continuously and signifi-cantly during the entire follow-up period (P .016 from 0-24
months and P .008 from 0-60 months) (Fig 3).
In group B, we observed continuous increase in TTL
volume. However, this increase was significant only with
regard to the entire follow-up period (P  .001 from 0-60
months), but not during the first 24 months (P .395 from
0-6 months and P .058 from 0-24 months). The FTL and
the TL increased continuously and significantly during the
entire follow-up period (FTL: P  .006 from 0-6 months,
P .004 from 0-24 months andP .001 from 0-60 months,
TL: P .002 from 0-6 months, P .001 from 0-24 months
and P .0001 from 0-60 months) (Fig 4).
The AL increased slightly in both groups. However,
volume increase was more pronounced in group A than in
group B (Fig 5).
In group A, TL volume increased by more than 10% in
9 patients (81.8%), it remained unchanged in 1 patient
lumen, thoracic lumen and diameter in patients treated
medians of the different lumina and of the diameter in
thoracic lumen; TL, thoracic lumen; D, diameter; SD,
ir.racic
and(9.1%) and in 1 patient (9.1%) it decreased.
L, tho
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16 patients (83.3%), it remained unchanged in 2 patients
(27.3%) and it decreased in none of the patients.
Circumscribed aneurismal degeneration of the aorta
immediately adjacent to the prosthesis was observed in 5
patients (13.5%).
Diametric measurements. Mean values  SD and
medians are given in Table I. Diameters in percentages are
shown in Figs 3-5.
Thrombosis. Thrombosis, if evident, was observed in
the thoracic region only. The results are given in Table II. In
most patients in group A, CT scans showed missing throm-
bosis pre-interventionally and partial thrombosis postinter-
ventionally, but no relevant changes at 60 months. In most
patients in group B, CT scans showed missing thrombosis on
admission and partial thrombosis at 60 months. In none of the
two groups was the association between the degree of throm-
Fig 4. Volume courses of true thoracic lumen, false th
treated patients. Mean values SD and medians of the d
TTL, True thoracic lumen; FTL, false thoracic lumen; Tbosis and volume outcome statistically significant.DISCUSSION
Many studies have shown that TEVAR is a valuable tool
in the therapy of complicated TBD with very encouraging
short-term results. Life-threatening symptoms can be sta-
bilized by TEVAR. However, it is of great importance, to
evaluate mid- and long-term results. As aortic lumen
changes are valuable prognostic factors for the outcome of
the disease,7,15,18,20,23 it is of great interest whether the
volume course in patients treated by TEVAR is different
from that in conservatively-treated patients.
Several authors have evaluated the applicability of volu-
metric measurements to the follow-up after endovascular
repair.21,24 It has been shown that intra- and interobserver
testing for CT-guided volume measurements has a repro-
ducibility coefficient of 5-10%21 and that volumetric mea-
surements are superior to simple diameter measurement in
lumen, thoracic lumen and diameter in conservatively
nt lumina and of the diameter in percentages are shown.
racic lumen; D, xxx; SD, standard deviation.oracic
ifferethe follow-up of patients treated for aortic aneurysms by
anda
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measurements are time consuming and, therefore, difficult
to practice in clinical routine. This may be the reason why
most centers prefer diameter measurements.3,4,17,18,27,28
We performed both volume and diameter measurements.
The results showed similar courses, which indicates that
diametric measurements are sufficient in the CT follow-up
of patients with TBD.
In our series, TEVAR resulted in the stabilization of the
aorta with significant increase in TTL volume and non-
Fig 5. Volume courses of the abdominal lumen in pa
endovascular aortic repair or conservatively. Mean values
in percentages are shown. AL, Abdominal lumen; SD, st
Table I. Maximal diameter in mm of groups A and B
Months 0 6 24 60
TEVAR Mean 43,7 44,6 47,6 53,7
n  11 (group A) SD 3,3 3,2 7,5 13,7
Median 44,0 44,5 49,6 54,0
Conservative Mean 40,8 43,4 46,1 47,2
n  18 (group B) SD 7,4 8,8 8,9 8,4
Median 40,5 41,3 45,2 46,5
TEVAR, Thoracic endovascular aortic repair; SD, standard deviation.
Mean values  SD and medians of the maximal aortic diameter in mm are
shown.significant decrease in FTL volume within 24 months. Ourresults are in agreement with those of Kusagawa et al.27
Their study included 17 patients with acute TBD and
diameter measurements, which were performed at 1, 6, 12,
and 24 months after TEVAR at different levels of the
descending aorta, showed increase in TTL, and decrease in
FTL diameters. Our analyses of the different aortic lumina
also showed that the TL volume increase observed in both
groups within the first 24 months was mainly due to a
significant increase in TTL volume in group A, whereas in
group B it was due to a significant increase in FTL volume.
These results are of concern, as it is well known that an
increase in FL volume raises the risk of aortic rupture15,29
and that an FL aneurysm is prone to rupture because of its
thin outer aortic wall.30
However, within 60 months, our results showed signif-
icant volume increase in all lumina in both patient groups,
except for FTL volumes in patients treated by TEVAR,
which showed non-significant increase. Within 60 months
the difference between the two groups became less obvi-
ous. This tendency was also observed when analyzing the
number of patients with volume increase or decrease of
more than 10%, as documented in the RESULTS section.
The approximation of the results indicates that TEVAR
treated for acute type B dissection, either by thoracic
and medians of the different lumina and of the diameter
rd deviation.tients
 SDmay delay but not stop the natural course of the disease.
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study groups will be of great interest.
The AL remained almost stable in both groups within
24 months. After that time, it increased slightly in group A,
whereas it remained nearly stable in group B. As none of the
patients showed thrombosis of the abdominal FL, we agree
with other authors who think that patency of the abdomi-
nal FL is responsible for a lack of remodeling of the abdom-
inal aorta despite adequate sealing of the proximal tears.15
Aneurismal dilatation immediately adjacent to the SG
has been observed by several authors.15,31,32 Although it
can be treated successfully in most cases by placing an
additional SG, problems arise when it occurs in the distal
part of the descending aorta involving the origin of the
celiac trunk and the superior mesenteric artery. In their
study, Won et al32 stated that the sharp stent tip, the
rigidity of the SG, and/or the pulsatile blood flow may have
induced this phenomenon. Lopera et al15 suggested that
new intimal tears caused by the SG may have triggered it. In
our study, aneurismal dilatation of the aorta in the area
immediately adjacent to the SG was observed in 5 patients.
Aortic rupture is fatal in most patients with TBD. In
our study, aortic rupture occurred in 3 of the conservative-
ly-treated patients but in none of the patients treated by
TEVAR. Several authors suggest that TEVAR can prevent
late aortic rupture.10,16,28,33-35 Eggebrecht et al12 re-
ported that aortic rupture occurred in 2.3% of 561 patients
over a mean follow-up of 19.5 months and that even in the
presence of a thrombosed false lumen, the distal thoracic or
abdominal aorta may enlarge over time. Therefore, possible
rupture has to be taken into consideration in case of sudden
onset of pain after TEVAR.
Thrombosis of the FL has been reported to be a good
indicator of a favorable long-term prognosis36 and Akutsu
et al37 stated that thrombosis of the FL lowered the risk of
aortic rupture. In their long-term study comparing 48
patients with patent FL to 62 with thrombosed FL, aortic
rupture resulting in death occurred in 10 patients with
Table II. Degree of thrombosis in the false thoracic lume
postinterventionally and at the 60 months follow-up in pat
of thrombosis in the false thoracic lumen as seen on compu
follow-up in conservatively treated patients
Patients
Degree of thrombosis
on the first CT % Patients
Degre
on the first
TEVAR
(n  11)
TEVAR
(n  11)
0 complete 0,0 1 c
3 partial 23,3 9 p
8 missing 72,7 1 m
Conservative
(n  18)
0 complete 0,0
5 partial 27,8
13 missing 72,2
TEVAR, Thoracic endovascular aortic repair; CT, computed tomography.patent FL compared to 2 patients with thrombosed FL.Bernard et al38 observed that FL patency in the descending
aorta is a predictive factor for late mortality. This is in agree-
ment with our results. Indeed, two of the conservatively-
treated patients who died of rupture, showed no throm-
bosis of the FTL. Interestingly, in another patient who
had partial thrombosis of the FTL, autopsy showed that
rupture had occurred exactly in a circumscribed bulged
area, where thrombosis was missing. However, no statisti-
cally significant correlation between the degree of throm-
bosis and TL volume course was observed. Our evaluation
of thrombosis of the FTL, showed slightly better overall
results in group A. In this group, we observed pronounced
changes between the pre- and the postinterventional CT
scans, but no relevant changes at 60 months, and our
analyses showed also a tendency towards approximation
between groups A and B within 5 years.
In conclusion, our analyses show that within 24
months volume courses are more favorable in patients after
TEVAR, than those in conservatively-treated patients and
that TEVAR promotes thrombus formation, which may
reduce the risk of rupture. However, within 60 months we
observed a tendency towards approximation between the
two patient groups, relating to both aortic volume courses
and thrombosis of the FTL. Therefore, we conclude that
TEVAR delays but does not stop the natural course of the
disease.
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